Inovio Pharmaceuticals (INO) FCF Margin (2010 - 2025)

Inovio Pharmaceuticals has disclosed FCF Margin across 16 years of filings, most recently posting 41218.49% for Q1 2025.

• In Q1 2025, FCF Margin changed N/A year-over-year to 41218.49%; the TTM figure through Dec 2025 stood at 136074.45% (down 8805539.0% YoY), while the FY2025 annual figure was 136074.45%, down 8805539.0% from the prior year.
• FCF Margin came in at 41218.49% for Q1 2025 at Inovio Pharmaceuticals, down from 16807.62% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 737.94% in Q3 2022 to a low of 41218.49% in Q1 2025.
• Average FCF Margin over 5 years is 19807.48%, with a median of 16807.62% recorded in 2024.
• The largest YoY upside for FCF Margin was 2234348 bps in 2022 against a maximum downside of 2469004 bps in 2022.
• Over 5 years, FCF Margin stood at 4592.32% in 2021, then plunged by 538 bps to 29282.36% in 2022, then increased by 13 bps to 25597.2% in 2023, then soared by 34 bps to 16807.62% in 2024, then tumbled by 145 bps to 41218.49% in 2025.
• Per Business Quant data, the three most recent FCF Margin figures were 41218.49% in Q1 2025, 16807.62% in Q4 2024, and 28040.54% in Q2 2024.